The Performance of a Commercial Radioligand Binding Assay for the Epidermal Growth Factor Receptor is Comparable to the EORTC Standard Assay

Author： Oberkanins C. Geurts-Moespot A. Zeillinger R. Kury F. Leake R.E. Benraad T.J.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.10, 1995-09, pp. : 1710-1711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies

By Blank Patricia

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 497-507

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Epidermal Growth Factor Receptor in Carcinoma of the Cervix

By Kim J.W. Kim Y.T. Kim D.K. Song C.H. Lee J.W.

Gynecologic Oncology, Vol. 60, Iss. 2, 1996-02 ,pp. : 283-287

Academic Press

Access to resources Recommend Favorite

Overexpression and activation of epidermal growth factor receptor in hemangioblastomas

By Chen Gregory Karajannis Matthias Newcomb Elizabeth Zagzag David

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 195-200

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition Induces Trichomegaly

By Dueland Svein Sauer Torill Lund-johansen Fridtjof Østenstad Bjørn Tveit Kjell Magne

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 345-346

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in cancer treatment

By Ciardiello Fortunato

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 221-234

Future Medicine

Access to resources Recommend Favorite